Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 19;4:CCI.20.00084. doi: 10.1200/CCI.20.00084

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: https://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG 3. — Overall survival (OS) by indication and frailty status. Median survival is represented by the dashed lines and reported in the legend. Solid red circles represent estimates of survival probabilities from the corresponding pivotal clinical trials extracted using the Engauge Digitizer software. 1L, first line; 2L+, second or subsequent line; HCC, hepatocellular carcinoma; ICI, immune checkpoint inhibitor; ipi, ipilimumab; nivo, nivolumab; NSCLC, non–small-cell lung cancer; pembro, pembrolizumab; RCC, renal cell carcinoma; SCCHN, squamous cell carcinoma of the head and neck.